These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 22672778)
41. Early-Life Nutritional Programming of Type 2 Diabetes: Experimental and Quasi-Experimental Evidence. Vaiserman AM Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273874 [TBL] [Abstract][Full Text] [Related]
42. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Inadera H Environ Health Prev Med; 2013 May; 18(3):185-97. PubMed ID: 23382021 [TBL] [Abstract][Full Text] [Related]
43. Recent developments on the role of epigenetics in obesity and metabolic disease. van Dijk SJ; Tellam RL; Morrison JL; Muhlhausler BS; Molloy PL Clin Epigenetics; 2015; 7():66. PubMed ID: 27408648 [TBL] [Abstract][Full Text] [Related]
44. [Influence of environmental pollutants on human gestation: Cause of adult pathologies]. Tchernitchin AN; Gaete L Rev Chil Pediatr; 2018 Dec; 89(6):761-765. PubMed ID: 30725066 [TBL] [Abstract][Full Text] [Related]
45. The Effects of High-Fat Diet Exposure In Utero on the Obesogenic and Diabetogenic Traits Through Epigenetic Changes in Adiponectin and Leptin Gene Expression for Multiple Generations in Female Mice. Masuyama H; Mitsui T; Nobumoto E; Hiramatsu Y Endocrinology; 2015 Jul; 156(7):2482-91. PubMed ID: 25853666 [TBL] [Abstract][Full Text] [Related]
46. Experimental models of developmental programming: consequences of exposure to an energy rich diet during development. Armitage JA; Taylor PD; Poston L J Physiol; 2005 May; 565(Pt 1):3-8. PubMed ID: 15695245 [TBL] [Abstract][Full Text] [Related]
47. Effects of Preconception and in Utero Inorganic Arsenic Exposure on the Metabolic Phenotype of Genetically Diverse Collaborative Cross Mice. Fry RC; Addo KA; Bell TA; Douillet C; Martin E; Stýblo M; Pardo-Manuel de Villena F Chem Res Toxicol; 2019 Aug; 32(8):1487-1490. PubMed ID: 31251040 [TBL] [Abstract][Full Text] [Related]
48. Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes. Vaag A; Brøns C; Gillberg L; Hansen NS; Hjort L; Arora GP; Thomas N; Broholm C; Ribel-Madsen R; Grunnet LG Acta Obstet Gynecol Scand; 2014 Nov; 93(11):1099-108. PubMed ID: 25179736 [TBL] [Abstract][Full Text] [Related]
49. The developmental basis of disease: Update on environmental exposures and animal models. Heindel JJ Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3():5-13. PubMed ID: 30265444 [TBL] [Abstract][Full Text] [Related]
50. Prenatal influences on susceptibility to diet-induced obesity are mediated by altered neuroendocrine gene expression. Ikenasio-Thorpe BA; Breier BH; Vickers MH; Fraser M J Endocrinol; 2007 Apr; 193(1):31-7. PubMed ID: 17400800 [TBL] [Abstract][Full Text] [Related]
51. The effects of early life stress on the epigenome: From the womb to adulthood and even before. Provençal N; Binder EB Exp Neurol; 2015 Jun; 268():10-20. PubMed ID: 25218020 [TBL] [Abstract][Full Text] [Related]
52. Epigenetics and human obesity. van Dijk SJ; Molloy PL; Varinli H; Morrison JL; Muhlhausler BS; Int J Obes (Lond); 2015 Jan; 39(1):85-97. PubMed ID: 24566855 [TBL] [Abstract][Full Text] [Related]
53. Allergic disease: understanding how in utero events set the scene. Prescott SL Proc Nutr Soc; 2010 Aug; 69(3):366-72. PubMed ID: 20587128 [TBL] [Abstract][Full Text] [Related]
54. Early life nutrition and metabolic programming. Fernandez-Twinn DS; Ozanne SE Ann N Y Acad Sci; 2010 Nov; 1212():78-96. PubMed ID: 21070247 [TBL] [Abstract][Full Text] [Related]
55. In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells. Cardenas A; Houseman EA; Baccarelli AA; Quamruzzaman Q; Rahman M; Mostofa G; Wright RO; Christiani DC; Kile ML Epigenetics; 2015; 10(11):1054-63. PubMed ID: 26646901 [TBL] [Abstract][Full Text] [Related]
56. Early Life Nutrition and Energy Balance Disorders in Offspring in Later Life. Reynolds CM; Gray C; Li M; Segovia SA; Vickers MH Nutrients; 2015 Sep; 7(9):8090-111. PubMed ID: 26402696 [TBL] [Abstract][Full Text] [Related]
57. Developmental and epigenetic pathways to obesity: an evolutionary-developmental perspective. Gluckman PD; Hanson MA Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S62-71. PubMed ID: 19136993 [TBL] [Abstract][Full Text] [Related]
58. Epigenetic responses and the developmental origins of health and disease. Goyal D; Limesand SW; Goyal R J Endocrinol; 2019 Jul; 242(1):T105-T119. PubMed ID: 31091503 [TBL] [Abstract][Full Text] [Related]
59. [The new paradigm of the developmental origin of health and diseases (DOHaD)--Epigenetics and environment: evidence and missing links]. Junien C; Panchenko P; Pirola L; Amarger V; Kaeffer B; Parnet P; Torrisani J; Bolaños Jimenez F; Jammes H; Gabory A Med Sci (Paris); 2016 Jan; 32(1):27-34. PubMed ID: 26850604 [TBL] [Abstract][Full Text] [Related]
60. One-Carbon Metabolism and Lipid Metabolism in DOHaD. Fukuoka H; Kubota T Adv Exp Med Biol; 2018; 1012():3-9. PubMed ID: 29956189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]